Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Neurological Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Explore advanced synthesis of indanone-piperidine compounds for neurodegenerative disease treatment. Reliable supply chain and cost-effective manufacturing solutions.
Novel Bartoli route for 7-methyl-5-oxygen substituted indoles. High purity, scalable, cost-effective pharma intermediate manufacturing.
Novel 3-step route for Pregabalin avoids resolution waste. High ee value up to 99.6%. Cost-effective manufacturing for pharma intermediates.
Discover the patented CN1170395A method for high-yield Galanthamine production. Enhance supply chain reliability and reduce manufacturing costs with our advanced intermediate solutions.
Patent CN101062897B details a novel Al-Ni alloy reduction for 2,3-dihydro-1H-inden-1-amine. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Patent CN103319374A details a high-yield asymmetric route for (S)-rivastigmine using Ellman auxiliary, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103288650A details a high-yield Memantine synthesis using phosphoric acid catalysis, offering significant cost reduction in pharmaceutical manufacturing and scalable supply chain solutions.
Novel Rh-catalyzed asymmetric hydrogenation route for Pramipexole. Higher yield, lower cost, industrial scale ready. Ideal for pharma intermediates.
Patent CN1247543C details a novel stereoselective synthesis for biperiden, offering superior exo/endo ratios and streamlined purification for reliable pharmaceutical intermediate supply chains.
Patent CN1280273C reveals a high-yield Donepezil synthesis route. Discover cost-effective manufacturing strategies for pharmaceutical intermediates with superior purity.
Patent CN1525964A reveals a novel high-purity Biperiden synthesis route. Discover cost-effective manufacturing solutions for Parkinson's disease API intermediates with superior stereocontrol.
Novel route for GABA-T inhibitor precursor via lactam rearrangement offering cost reduction and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN103224467A details a cost-effective resolution method for (-)-Huperzine A, achieving >99.5% purity and significantly reducing manufacturing costs for pharmaceutical applications.
Patent CN102002004A reveals a scalable liquid phase route for Taltirelin intermediates, offering significant cost reduction and simplified purification for pharmaceutical manufacturing.
Patent CN110577974B reveals a green enzymatic route for high-purity chiral tetrahydropyridines, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Discover a novel 4-step synthesis for Piribedil offering >99% purity. This metal-free route ensures cost reduction in API manufacturing and scalable supply.
Patent CN101935302A details a novel organocatalytic route for Huperzine A intermediates, offering high optical purity and eliminating precious metal dependency for reliable pharmaceutical intermediate supply.
Advanced asymmetric total-synthesis method for chiral Huperzine A using Cinchona alkaloids. Delivers high optical purity and scalable manufacturing for Alzheimer's therapeutics.
Patent CN103275146A details a novel Lewis acid-catalyzed route for gastrodin, offering significant cost reduction in API manufacturing and enhanced supply chain reliability through stable intermediates.
Patent CN102260255B reveals a cost-effective two-step synthesis for 9,10-dimethoxy-3-isobutyl-benzo[a]quinolizidine-2-one using water media, offering significant supply chain advantages.